Your browser doesn't support javascript.
loading
Exploring the presence of narcolepsy in patients with schizophrenia.
Sansa, Gemma; Gavaldà, Alba; Gaig, Carles; Monreal, José; Ercilla, Guadalupe; Casamitjana, Roser; Ribera, Gisela; Iranzo, Alex; Santamaria, Joan.
Afiliação
  • Sansa G; Neurology Service and Multidisciplinary Sleep Disorders Unit, Hospital Parc Taulí, Sabadell, Spain. gsansa@tauli.cat.
  • Gavaldà A; Neuropsychology Department, Neurology Service. Hospital Parc Taulí, Sabadell, Spain.
  • Gaig C; Neurology Service and Multidisciplinary Sleep Disorders Unit, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Monreal J; Psychiatry Service, Hospital Parc Taulí, Sabadell, Spain.
  • Ercilla G; Immunology Laboratory, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Casamitjana R; Biochemistry and Molecular Genetics Laboratory, Centre de Diagnòstic Biomèdic (CDB), Hospital Clínic of Barcelona, Barcelona, Spain.
  • Ribera G; Neurology Service and Multidisciplinary Sleep Disorders Unit, Hospital Parc Taulí, Sabadell, Spain.
  • Iranzo A; Neurology Service and Multidisciplinary Sleep Disorders Unit, Hospital Clínic of Barcelona, Barcelona, Spain.
  • Santamaria J; Neurology Service and Multidisciplinary Sleep Disorders Unit, Hospital Clínic of Barcelona, Barcelona, Spain.
BMC Psychiatry ; 16: 177, 2016 06 01.
Article em En | MEDLINE | ID: mdl-27245445
BACKGROUND: There are several case reports of patients with narcolepsy and schizophrenia, but a systematic examination of the association of both disorders has not been done. The aim of this work is to assess the frequency of narcolepsy with cataplexy in a large consecutive series of adult patients with schizophrenia and schizoaffective disorder. METHODS: We screened 366 consecutive patients with schizophrenia or schizoaffective disorder with a sleep questionnaire and the Epworth Sleepines scale (ESS) exploring narcoleptiform symptoms. Those who screened positive were assessed by a sleep specialist, and offered an HLA determination. CSF hypocretin-1 determination was proposed to those who were HLA DQB1*06:02 positive. RESULTS: On the screening questionnaire, 17 patients had an ESS score ≥11 without cataplexy, 15 had cataplexy-like symptoms with an ESS score < 11, and four had an ESS score ≥11 plus cataplexy-like symptoms. Of those, 24 patients were evaluated by a sleep specialist. Five of these 24 were HLA DQB1*06:02 positive, and three of these five subjects underwent lumbar puncture showing normal hypocretin-1 levels. CONCLUSIONS: Our results suggest that narcolepsy with cataplexy is not an unrecognized disease in adult patients with schizophrenia or schizoaffective disorder.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Narcolepsia Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Psychiatry Assunto da revista: PSIQUIATRIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Narcolepsia Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Psychiatry Assunto da revista: PSIQUIATRIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha